Human papillomavirus outcomes in an access-to-care laryngeal cancer cohort

Otolaryngology - Head and Neck Surgery (United States)

Volumn 146, Issue 5, 2012, Pages 730-738

  Stephen, Josena K ^a   Chen, Kang Mei ^a   Shah, Veena ^a   Havard, Shaleta ^a   Lu, Mei ^a   Schweitzer, Vanessa P ^a   Gardner, Glendon ^a   Worsham, Maria J ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

gender; HPV; insurance; laryngeal squamous cell cancer; race; stage; survival outcomes

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FEMALE; FISHER EXACT TEST; GENDER; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; INFECTION RISK; KAPLAN MEIER METHOD; LARYNGEAL SQUAMOUS CELL CANCER; LARYNX CANCER; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIMARY MEDICAL CARE; PROGNOSIS; RACE; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; VIRUS DETECTION; WART VIRUS; CHI SQUARE DISTRIBUTION; ETHNOLOGY; ISOLATION AND PURIFICATION; LARYNX TUMOR; MIDDLE AGED; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; UNITED STATES; VIROLOGY;

AGED; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LARYNGEAL NEOPLASMS; MALE; MICHIGAN; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 84864023339     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811434482     Document Type: Article

References (31)

1. Gillison ML, Lowy DR. A causal role for human papillomavirus in head and neck cancer. Lancet. 2004 ; 363 (9420). 1488-1489
2. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000 ; 92 (9). 709-720 (Pubitemid 30365531)
3. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010 ; 363 (1). 24-35
4. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007 ; 356 (19). 1944-1956 (Pubitemid 46740304)
5. Chen AA, Marsit CJ, Christensen BC, et al. Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. Carcinogenesis. 2009 ; 30 (6). 977-981
6. Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010 ; 2: 15
7. Kreimer AR, Clifford GM, Boyle P, Franceschi S.. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005 ; 14 (2). 467-475 (Pubitemid 40270113)
8. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004 ; 31 (6). 744-754 (Pubitemid 39602680)
9. J Virol. Munger K Baldwin A Edwards KM, ed. 2004: 11451-11460.
10. Nguyen M, Song S, Liem A, Androphy E, Liu Y, Lambert PF. A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo. J Virol. 2002 ; 76 (24). 13039-13048 (Pubitemid 35386988)
11. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008 ; 100 (4). 261-269 (Pubitemid 351480538)
12. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol. 2006 ; 24 (17). 2606-2611 (Pubitemid 46622080)
13. Settle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila Pa). 2009 ; 2 (9). 776-781
14. Sethi S, Lu M, Kapke A, Benninger MS, Worsham MJ. Patient and tumor factors at diagnosis in a multi-ethnic primary head and neck squamous cell carcinoma cohort. J Surg Oncol. 2009 ; 99 (2). 104-108
15. Piccirillo JF, Costas I, Claybour P, Borah AJ, Grove L, Jeffe D.. The measurement of comorbidity by cancer registries. J Reg Manage. 2003 ; 30 (1). 8-14
16. Naqvi K, Garcia-Manero G, Sardesai S, et al. Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model. J Clin Oncol. 2011 ; 29 (16). 2240-2246
17. Chen K, Sawhney R, Khan M, et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2007 ; 133 (11). 1131-1138 (Pubitemid 350157026)
18. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998 ; 62 (4). 768-775 (Pubitemid 28194317)
19. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol. 2002 ; 40 (3). 886-891 (Pubitemid 34208640)
20. User Bulletin #2: ABI Prism 7700 Sequence Detection System. Foster City, CA: Perkin-Elmer Corporation ; 1997: 1-36.
21. Gallo A, Degener AM, Pagliuca G, et al. Detection of human papillomavirus and adenovirus in benign and malignant lesions of the larynx. Otolaryngol Head Neck Surg. 2009 ; 141 (2). 276-281
22. Gallegos-Hernandez JF, Paredes-Hernandez E, Flores-Diaz R, Minauro-Munoz G, Apresa-Garcia T, Hernandez-Hernandez DM. Human papillomavirus: association with head and neck cancer. Cir Cir. 2007 ; 75 (3). 151-155
23. Torrente MC, Rodrigo JP, Haigentz M, et al. Human papillomavirus infections in laryngeal cancer. Head Neck. 2011 ; 33 (4). 581-586
24. Ha PK, Pai SI, Westra WH, et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res. 2002 ; 8 (5). 1203-1209 (Pubitemid 34517659)
25. Settle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila). 2009 ; 2 (9). 776-781
26. Baumann JL, Cohen S, Evjen AN, et al. Human papillomavirus in early laryngeal carcinoma. Laryngoscope. 2009 ; 119 (8). 1531-1537
27. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008 ; 26 (19). 3138-3146
28. Chen AY, Schrag NM, Halpern M, Stewart A, Ward EM. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis?. Arch Otolaryngol Head Neck Surg. 2007 ; 133 (8). 784-790 (Pubitemid 47295759)
29. Kwok J, Langevin SM, Argiris A, Grandis JR, Gooding WE, Taioli E. The impact of health insurance status on the survival of patients with head and neck cancer. Cancer. 116 (2). 476-485
30. Gorgoulis VG, Zacharatos P, Kotsinas A, et al. Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol. 1999 ; 30 (3). 274-283 (Pubitemid 29125146)
31. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003 ; 95 (23). 1772-1783 (Pubitemid 38008900)